Biomemory
Biomemory provides biodigital data storage for large companies and administrations.
Biomemory provides biodigital data storage for large companies and administrations.
Biomemory, a French biotechnology startup founded in 2014, offers biodigital data storage solutions targeting large companies and administrations. The company's DNA Drives serve as a unique approach to organizing and storing data on biocompatible DNA molecules. In November 2022, Biomemory secured a significant milestone with a €5.00M Seed Round investment, backed by a diverse group of investors including Bpifrance, eureKARE, Flavien Kulawik, Jean-David Benichou, Paris Business Angels, Prunay Impact Studio, Octave Klaba, Eric Carreel, and Radouane Kharbichi. This strategic influx of funding denotes a strong vote of confidence in Biomemory's innovative approach and underscores the growing interest in biotechnology as an industry. With its focus on biodigital data storage, Biomemory is carving a niche in a field that holds immense potential for disruption and scalability, positioning itself as a promising player in the evolving landscape of data storage and biotechnology.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | €5.00M | 9 |
|
28 Nov 2022 |
| Non Equity Assistance | Unknown | 1 |
|
13 Sep 2021 |
No recent news or press coverage available for Biomemory.
We care about your data, and we'd love to use cookies make your experience better.